DE60221352D1 - Zusammensetzung und kit zur verwendung in der tumorbehandlung - Google Patents

Zusammensetzung und kit zur verwendung in der tumorbehandlung

Info

Publication number
DE60221352D1
DE60221352D1 DE60221352T DE60221352T DE60221352D1 DE 60221352 D1 DE60221352 D1 DE 60221352D1 DE 60221352 T DE60221352 T DE 60221352T DE 60221352 T DE60221352 T DE 60221352T DE 60221352 D1 DE60221352 D1 DE 60221352D1
Authority
DE
Germany
Prior art keywords
tumor
kit
composition
tumor treatment
tumor tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60221352T
Other languages
English (en)
Other versions
DE60221352T2 (de
Inventor
Eugene Roussel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BioTHER Corp
Original Assignee
BioTHER Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BioTHER Corp filed Critical BioTHER Corp
Application granted granted Critical
Publication of DE60221352D1 publication Critical patent/DE60221352D1/de
Publication of DE60221352T2 publication Critical patent/DE60221352T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
DE60221352T 2001-01-09 2002-01-09 Zusammensetzung und kit zur verwendung in der tumorbehandlung Expired - Lifetime DE60221352T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/756,978 US7041302B2 (en) 2001-01-09 2001-01-09 Therapeutic modulation of the tumor inflammatory response
US756978 2001-01-09
PCT/US2002/000749 WO2002055024A2 (en) 2001-01-09 2002-01-09 Therapeutic modulation of the tumor inflammatory response

Publications (2)

Publication Number Publication Date
DE60221352D1 true DE60221352D1 (de) 2007-09-06
DE60221352T2 DE60221352T2 (de) 2008-04-17

Family

ID=25045839

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60221352T Expired - Lifetime DE60221352T2 (de) 2001-01-09 2002-01-09 Zusammensetzung und kit zur verwendung in der tumorbehandlung

Country Status (9)

Country Link
US (2) US7041302B2 (de)
EP (2) EP1769805A1 (de)
AT (1) ATE367825T1 (de)
AU (1) AU2002251754A1 (de)
CA (1) CA2434171C (de)
DE (1) DE60221352T2 (de)
ES (1) ES2290283T3 (de)
MX (1) MXPA03006153A (de)
WO (1) WO2002055024A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7927612B2 (en) * 2000-01-19 2011-04-19 Baofa Yu Combinations and methods for treating neoplasms
CN1175819C (zh) * 2001-12-24 2004-11-17 冯威健 盐酸在制备治疗实体肿瘤致其坏死的注射液中的应用
JP2006519784A (ja) * 2003-01-28 2006-08-31 シャンハイ、サンウエイ、バイアテク、カムパニ、リミティド 原発癌および転移癌に対する治療（ａ２）温熱療法と腫瘍溶解の同時治療（ａ３）
CA2591702A1 (en) * 2004-12-16 2006-07-27 Cavit Sciences, Inc. Methods and compositions for treatment of viral infections
US20070161546A1 (en) * 2005-12-15 2007-07-12 Colm King Methods and compositions for treatment of cancer
CN101138634A (zh) 2006-09-07 2008-03-12 于保法 用于治疗肿瘤的组合物
EA009325B1 (ru) * 2007-03-07 2007-12-28 Петр Генриевич ЛОХОВ Противоопухолевая вакцина, способ получения противоопухолевой вакцины и способ проведения противоопухолевой иммунотерапии
EP2136838B1 (de) * 2007-03-08 2017-03-08 KaloBios Pharmaceuticals, Inc. Ep ha3-antikörper zur behandlung von soliden tumoren
WO2014151465A1 (en) * 2013-03-15 2014-09-25 Board Of Regents, The University Of Texas System Brain-specific gene signature of tumor cells
SG11201704175WA (en) 2014-11-26 2017-06-29 Baofa Yu Hapten-enhanced chemoimmunotherapy by ultra-minimum incision personalized intratumoral chemoimmunotherapy

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5082658A (en) 1984-01-16 1992-01-21 Genentech, Inc. Gamma interferon-interleukin-2 synergism
US4879111A (en) 1986-04-17 1989-11-07 Cetus Corporation Treatment of infections with lymphokines
EP0310136B1 (de) * 1987-10-02 1997-02-26 The Rockefeller University Von Makrophagen abstammender Entzündungsvermittler(MIP-1-alpha et MIP-1-beta)
US5154921A (en) * 1990-07-13 1992-10-13 Dana-Farber Cancer Institute, Inc. Promotion of maturation of hematopoietic progenitor cells
JPH08501085A (ja) 1992-08-26 1996-02-06 プレジデント アンド フェローズ オブ ハーバード カレッジ 抗腫瘍剤としてのサイトカインｉｐ−１０の利用
DE4235911A1 (de) 1992-10-23 1994-04-28 Asta Medica Ag Stabilisierte Hexadecylphosphocholinlösungen in Glycerinalkylethern
US5871723A (en) 1995-06-06 1999-02-16 The Regent Of The University Of Michigan CXC chemokines as regulators of angiogenesis
EP0971728B1 (de) * 1997-02-21 2002-12-11 Vlaams Interuniversitair Instituut voor Biotechnologie vzw. Verwendung von interleukin-15
US6011047A (en) * 1997-11-26 2000-01-04 Corvas International Inc. Substituted 3-amino-2-hydroxyphenylacetamide derivatives as enzyme inhibitors
DE19822509A1 (de) 1998-05-19 1999-11-25 Medmark Pharma Gmbh Edelfosin zur Behandlung von Hirntumoren
DE19829448A1 (de) 1998-07-01 2000-10-12 Medmark Pharma Gmbh 1-Octadecyl-2-methyl-sn-glycero-3-phosphocholin (ET180CH3) zur Behandlung von humanen Mammakarzinomen
US20020090381A1 (en) * 1999-04-09 2002-07-11 H. Kim Bottomly System for controlling immune system response to antigen
US6811788B2 (en) * 2000-01-19 2004-11-02 Baofa Yu Combinations and methods for treating neoplasms
ES2164011B1 (es) 2000-02-25 2003-05-16 Inst Cientifico Tecnol Navarra Uso combinado de la quimiocina ip-10 y la interleucina-12 en la preparacion de composiciones para el tratamiento de tumores malignos.

Also Published As

Publication number Publication date
ES2290283T3 (es) 2008-02-16
CA2434171C (en) 2015-04-07
MXPA03006153A (es) 2005-02-14
EP1355660B1 (de) 2007-07-25
DE60221352T2 (de) 2008-04-17
EP1355660A4 (de) 2004-06-16
AU2002251754A1 (en) 2002-07-24
US7871630B2 (en) 2011-01-18
EP1355660A2 (de) 2003-10-29
WO2002055024A2 (en) 2002-07-18
EP1769805A1 (de) 2007-04-04
US7041302B2 (en) 2006-05-09
US20050276786A1 (en) 2005-12-15
US20020090353A1 (en) 2002-07-11
ATE367825T1 (de) 2007-08-15
CA2434171A1 (en) 2002-07-18
WO2002055024A3 (en) 2003-02-27

Similar Documents

Publication Publication Date Title
BRPI0207961B8 (pt) uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos.
DE602005013811D1 (de) Behandlung von fettsucht und verbundenen erkrankungen
ATE199746T1 (de) Geerbte und somatische mutationen des apc-gens bei menschlichem colorectal-krebs
MXPA03006771A (es) Anticuerpos modificados y metodos de uso.
ME00425B (me) Liječenje sa anti-vegf antitijelima
DK1368060T3 (da) HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme
SE9800836D0 (sv) New Compounds
ATE331534T1 (de) Anwendung von zielgerichtetem radium 223 für palliative und therapeutische behandlung von knochenkrebs
ATE380548T1 (de) Verwendung von p53 inhibitoren zur behandlung von nebenerscheinungen bei der krebstherapie
MX338122B (es) Epitopes terapeuticos y usos de los mismos.
ATE329587T1 (de) Zusammensetzungen zur verwendung bei der behandlung der osteoporose und/oder der entzündlichen gelenkerkrankungen
NO20061911L (no) Immunogene sammensetninger
HUP0303917A2 (hu) Szterin abszorpció inhibitor(ok) kombinációi vérmódosítókkal és ezek alkalmazása vaszkuláris kondíciók kezelésére
MXPA05008438A (es) Heterociclil-3-sulfonilindazoles como ligandos de 5-hidroxitriptamina-6.
DE60221352D1 (de) Zusammensetzung und kit zur verwendung in der tumorbehandlung
ATE336996T1 (de) Verwendung von flavonoid-derivaten zur behandlung von atopischem ekzem
ATE419018T1 (de) Wärme erzeugende biokompatible keramikmaterialien
ATE450622T1 (de) Gene und proteine für verhinderung, vorhersage, prognose und therapie der herzgefäss-krankheit
DE602004020266D1 (de) Therapeutische und diagnostische anti-hsp 70-antikörper
SI1546182T1 (sl) Sestavki in postopki za diagnozo in zdravljenje tumorja
ATE527377T1 (de) Erstellung von genexpressionprofilen aus ffpe- proben
DE60224004D1 (de) Verwendung von il-18 hemmern zur behandlung und/oder prävention von herzkrankheiten
NO20060781L (no) Anvendelse av loselig CD164 ved inflammatoriske og/eller autoimmune lidelser
TR200200278T2 (tr) Kalsilitik bileşimler
ATE382347T1 (de) Pharmazeutische zusammensetzung zur verwendung bei der behandlung von malignen erkrankungen, umfassend eine kombination aus bisphosphonaten, einem cox-2 inhibitor und einem taxol

Legal Events

Date Code Title Description
8364 No opposition during term of opposition